These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2023442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relationship of blood flow effects of adenosine during reperfusion to recovery of ventricular function after hypothermic ischemia in neonatal lambs.
    Nomura F, Forbess JM, Hiramatsu T, Mayer JE.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-227-32. PubMed ID: 9386103
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R, Chambers DJ.
    J Thorac Cardiovasc Surg; 2001 Nov 04; 122(5):993-1003. PubMed ID: 11689806
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
    Rousou JA, Engelman RM, Breyer RH, Otani H, Lemeshow S, Das DK.
    J Thorac Cardiovasc Surg; 1988 Apr 04; 95(4):625-30. PubMed ID: 3352296
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The protective effect of puerarin against myocardial reperfusion injury. Study on cardiac function.
    Fan LL, Sun LH, Li J, Yue XH, Yu HX, Wang SY.
    Chin Med J (Engl); 1992 Jan 04; 105(1):11-7. PubMed ID: 1576864
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of 2,3-butanedione monoxime in isolated hearts: protection during reperfusion after global ischemia.
    Boban M, Stowe DF, Kampine JP, Goldberg AH, Bosnjak ZJ.
    J Thorac Cardiovasc Surg; 1993 Mar 04; 105(3):532-40. PubMed ID: 8445931
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion.
    Engelman DT, Watanabe M, Maulik N, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK.
    Circulation; 1996 Nov 01; 94(9 Suppl):II407-11. PubMed ID: 8901782
    [Abstract] [Full Text] [Related]

  • 20. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM, DeBoer LW, Geffin GA, O'Keefe DD, Fallon JT, Aretz TH, Haas GS, Daggett WM.
    J Thorac Cardiovasc Surg; 1983 May 01; 85(5):769-80. PubMed ID: 6843158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.